Silver Oak Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Silver Oak Securities's ABBV Position: Q2 2026 in Review
Silver Oak Securities increased its AbbVie (ABBV) stake by 118% in Q2 2026, buying an estimated $2.97M and bringing the position to 25,544 shares worth $6.43M. The position accounts for 0.39% of the portfolio, ranked #52.
Silver Oak Securities first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Silver Oak Securities held 25,544 shares of AbbVie worth $6.43M as of Q2 2026.
- Silver Oak Securities bought 13,819 AbbVie shares in Q2 2026, an estimated $2.97M.
- AbbVie made up 0.39% of Silver Oak Securities's portfolio in Q2 2026, its #52 holding.
- Silver Oak Securities first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.